GSK Investigational Site

Parma 43126

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Multiple Myeloma

Studies at this site

• A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody — Completed
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed